Keith Lyndon Mccormick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2047 Valleygate Dr, Fayetteville, NC 28304 Phone: 910-485-3937 |
Xinxin Zhang, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1726 Metromedical Dr, Fayetteville, NC 28304 Phone: 910-484-2284 |
Judith Anne Rodnite, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7300 S Raeford Rd, Fayetteville, NC 28304 Phone: 910-488-2120 |
Jeffrey William Moon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2817 Reilly Rd, Fort Bragg, NC 28310 Phone: 910-907-6000 |
Scott Daniel Barnes, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2817 Reilly Road Mcxc-cod Credentials, Womack Army Medical Center, Fort Bragg, NC 28310 Phone: 910-907-8922 Fax: 910-907-6069 |
Anton Vlasov, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2817 Reilly St, Fort Bragg, NC 28310 Phone: 910-907-6001 |
Katelyn Elizabeth Earls, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2817 Rock Merritt Ave 5 South Dos- Ophthalmology, Fort Liberty, NC 28310 Phone: 910-907-6423 Fax: 910-907-8614 |
Dr. Charles Alva Shaller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 36 Westgate Plz, Franklin, NC 28734 Phone: 828-369-4236 Fax: 828-369-0753 |
Mr. Hasmukh Amritlal Mithani, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2817 Reilly Rd, Wamc Opthamology Section, Ft Bragg, NC 28310 Phone: 910-907-6001 Fax: 910-907-8614 |
Kenneth William Roach, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Main St, Suite #204, Fuquay Varina, NC 27526 Phone: 919-567-3709 |
John A Lowery, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Ste A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-8029 |
Dr. Bobby Kenneth Mccullen Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Ste A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Richard Edwin Akers, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2555 Court Drive, Suite 150, Gastonia, NC 28054 Phone: 704-864-7789 Fax: 704-864-4884 |
Dr. Martin Todd Brown, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Ste A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Michon Tran, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 401 Cox Rd Ste 166, Gastonia, NC 28054 Phone: 704-865-7077 |
Dr. William Bartholomew Shannon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1061 X Ray Dr, Gastonia, NC 28054 Phone: 704-861-8557 Fax: 704-853-0003 |
Dr. Michael James Lund, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Ste A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Bryan Ewing Allf, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 111 E 3rd Ave, Gastonia, NC 28052 Phone: 704-874-3300 |
Dr. Daniel Paul Lee, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Gastonia, NC 28054 Phone: 704-853-3937 |
Harcharan Singh, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 111 E.third Avenue, Gaston Family Medical Center,, Gastonia, NC 28052 Phone: 704-874-9010 |
News Archive
SAFC®, a member of the Sigma-Aldrich® Group, today announced the opening of a $30 million expansion to its Madison Manufacturing facility in Verona, Wisconsin.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, presented updated preliminary data from an ongoing randomized Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.
Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells - responsible for a usually fatal type of brain cancer - and could be applicable to other highly aggressive cancers.
Anacor Pharmaceuticals announced today that it has entered into a loan agreement led by Oxford Finance Corporation and partnered with Horizon Technology Finance Corporation to provide up to $30 million in capital. Anacor used $6.6 million to repay the remaining obligations under its loan agreement with Lighthouse Capital Partners and expects to use the remainder of the capital to fund development activities related to AN2690, AN2728 and AN2898.
› Verified 9 days ago